Abbreviated Protocol for Two-Stage Exchange

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

March 13, 2023

Study Completion Date

December 22, 2023

Conditions
Prosthetic Joint Infection
Interventions
COMBINATION_PRODUCT

VT-X7 Treatment System with Tobramycin Sulfate

Seven-day local antibiotic irrigation with tobramycin sulfate via the VT-X7 Knee or Hip Spacer.

DRUG

Standard of Care

Forty-two days (minimum) systemic antibiotic administration adjuvant to two-stage exchange arthroplasty with temporary antibiotic-impregnated cement spacer per standard of care. Antibiotics will be selected by treatment provider and administered in accordance with national and local treatment guidelines.

PROCEDURE

Two-stage exchange arthroplasty

Stage 1 consists of surgical removal of the infected prosthesis, debridement, and implantation of a temporary spacer. Stage 2 surgery consists of explantation of the temporary spacer, debridement, and implantation of a permanent prosthesis, followed by systemic administration of postoperative antibiotics for 42 days (inclusive) to 90 days (inclusive).

COMBINATION_PRODUCT

VT-X7 Treatment System with Vancomycin Hydrochloride

Seven-day local antibiotic irrigation with vancomycin hydrochloride via the VT-X7 Knee or Hip Spacer.

Trial Locations (17)

10003

New York University, New York

10032

Columbia, New York

19107

Rothman Orthopaedic Institute, Philadelphia

20422

VA Medical Center, Washington D.C.

22903

UVA Orthopedics Center, Charlottesville

28207

OrthoCarolina Research Institute, Inc, Charlotte

32611

University of Florida, Gainesville

33331

Cleveland Clinic, Weston

40506

University of Kentucky, Lexington

43202

Ohio State University, Columbus

44195

Cleveland Clinic, Cleveland

48602

Covenant Medical Center, Saginaw

73103

Integris Southwest Medical Center, Oklahoma City

75093

Texas Health Presbyterian, Plano

84108

University of Utah, Salt Lake City

85004

University of Arizona, Phoenix, Phoenix

90502

Harbor-UCLA Medical Center, Torrance

Sponsors
All Listed Sponsors
lead

Osteal Therapeutics, Inc.

INDUSTRY

NCT04662632 - Abbreviated Protocol for Two-Stage Exchange | Biotech Hunter | Biotech Hunter